ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Fisher expands in diagnostics

March 20, 2006 | APPEARED IN VOLUME 84, ISSUE 12

Fisher Scientific has entered a definitive agreement to acquire privately held Athena Diagnostics, a developer of neurologic, nephrologic, and endocrine diagnostic tests, from Behrman Capital for $283 million. Fisher also agreed to buy a 9% stake in Nanogen, a manufacturer of diagnostic equipment, microarrays, and reagents, for $15 million. Fisher says it will collaborate with Nanogen to develop Athena's proprietary markers and diagnostic assays.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment